Neuropace, Inc. (NPCE) earnings
NPCE earnings moved a median of +1.29% by the close. Quarterly and annual NPCE reports and results, each read against the price at its own news timestamp. Back to the NPCE overview →
28 measured NPCE earnings events.
Where these NPCE earnings landedvs 28 measured NPCE earnings reactions
| Middle 50% of NPCE earnings reactions | -2.92% to +6.61% |
|---|---|
| Median reaction (to close) | +1.29% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 NPCE earnings events with a measured close landed between -2.92% and +6.61%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NeuroPace Inc For: Jun 30 | SEC filing · Form 10-Q | +0.25% | +2.83% | |
| NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance | Press release | +0.25% | +2.83% | |
| Form 10-Q NeuroPace Inc For: Mar 31 | SEC filing · Form 10-Q | -7.96% | +6.61% | |
| NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance | Press release | -7.96% | +6.61% | |
| NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026 | Press release | +0.48% | +0.78% | |
| Form 10-K NeuroPace Inc For: Dec 31 | SEC filing · Form 10-K | -1.79% | -9.88% | |
| NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 | Press release | +0.04% | +2.61% | |
| Form 10-Q NeuroPace Inc For: Sep 30 | SEC filing · Form 10-Q | -5.59% | +11.61% | |
| NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | Press release | -5.59% | +11.61% | |
| NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 | Press release | +0.74% | +0.56% | |
| Form 10-Q NeuroPace Inc For: Jun 30 | SEC filing · Form 10-Q | -9.38% | +4.13% | |
| NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | Press release | -9.38% | +4.13% | |
| NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 | Press release | +0.00% | -0.68% | |
| Form 10-Q NeuroPace Inc For: Mar 31 | SEC filing · Form 10-Q | -0.70% | +9.09% | |
| NeuroPace Reports First Quarter 2025 Financial Results | Press release | -0.70% | +9.09% | |
| Form 10-K NeuroPace Inc For: Dec 31 | SEC filing · Form 10-K | -6.32% | -8.06% | |
| Form 10-Q NeuroPace Inc For: Sep 30 | SEC filing · Form 10-Q | +3.14% | +18.52% | |
| NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance | Press release | +3.14% | +18.52% | |
| NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 | Press release | -0.17% | -1.99% | |
| Form 10-Q NeuroPace Inc For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -7.26% | |
| NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance | Press release | +0.00% | -7.26% | |
| NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024 | Press release | +3.65% | -4.95% | |
| Form 10-Q NeuroPace Inc For: Mar 31 | SEC filing · Form 10-Q | -17.87% | -35.83% | |
| NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -17.87% | -35.83% | |
| NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 | Press release | +0.00% | +1.16% | |
| Form 10-K NeuroPace Inc For: Dec 31 | SEC filing · Form 10-K | -0.04% | -2.24% | |
| Form 10-Q NeuroPace Inc For: Sep 30 | SEC filing · Form 10-Q | +0.43% | +1.29% | |
| NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance | Press release | +0.43% | +1.29% |
Keep exploring
More NPCE: analyst actions → · SEC filings → · NPCE overview →